New cancer drug BNT3214 enters first human trials for advanced solid tumors
NCT ID NCT07455734
First seen Mar 09, 2026 · Last updated May 07, 2026 · Updated 7 times
Summary
This study is the first time the experimental drug BNT3214 is being tested in people. It aims to find a safe dose and see if it can shrink tumors in adults with advanced solid cancers that have not responded to other treatments. About 533 participants will take part across multiple sites worldwide.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Epworth HealthCare
NOT_YET_RECRUITINGRichmond, 3121, Australia
-
Monash Medical Centre Clayton
NOT_YET_RECRUITINGFitzroy, 3065, Australia
-
National Taiwan University Hospital
NOT_YET_RECRUITINGTaipei, 100225, Taiwan
-
Shanghai East Hospital
RECRUITINGShanghai, 200120, China
Conditions
Explore the condition pages connected to this study.